Notably, lower-grade DDLPS exhibits a higher FRS2/CEP12 ratio, compared with ALT/WDLPS.[19,20] Surgical resection remains the primary treatment modality for rare DDLPS cases transforming into low-grade sarcoma components. The gene discussed is FRS2; the disease is dedifferentiated liposarcoma.